Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ).

导出 LinkOut

翻译打印收藏纠错

作者： Oliver,Ristow ^[1] ; Sven,Otto ^[2] ; Matthias,Troeltzsch ^[2] ; Bettina,Hohlweg-Majert ^[3] ; Christoph,Pautke ^[4]

作者单位： University of Heidelberg, Department of Oral and Maxillofacial Surgery, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany; Medizin & Aesthetik, Clinic for Oral and Maxillofacial and Plastic Surgery, Lenbachplatz 2a, D-80333 Munich, Germany. Electronic address: oliver.ristow@med.uni-heidelberg.de. ^[1] Ludwig-Maximilians Universität München, Department of Oral and Maxillofacial Surgery, Lindwurmstr. 2a, D-80336 Munich, Germany. ^[2] Medizin & Aesthetik, Clinic for Oral and Maxillofacial and Plastic Surgery, Lenbachplatz 2a, D-80333 Munich, Germany; Technische Universität München, Department of Oral and Maxillofacial Surgery, Ismaninger Str. 22, D-81675 Munich, Germany. ^[3] Medizin & Aesthetik, Clinic for Oral and Maxillofacial and Plastic Surgery, Lenbachplatz 2a, D-80333 Munich, Germany; Ludwig-Maximilians Universität München, Department of Oral and Maxillofacial Surgery, Lindwurmstr. 2a, D-80336 Munich, Germany. ^[4]

关键词 BRONJ Bisphosphonate Denosumab Fluorescence-guided bone resection Osteonecrosis of the jaw Surgical treatment

主题词清创术(Debridement);疾病恶化(Disease Progression);荧光(Fluorescence);人类(Humans);手术中医护(Intraoperative Care);截骨术(Osteotomy);治疗结果(Treatment Outcome)

DOI 10.1016/j.jcms.2014.11.014

PMID 25541255

发布时间 2017-01-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交